Chondroitin sulfate proteoglycan (CSPG) inhibits outgrowth from embryonic chick and
rodent neurons in vivo and in vitro and is upregulated during development and following …

The chondroitin sulfate proteoglycans (CSPGs) have been implicated as both positive and
negative modulators of axonal growth; however, the functional properties of only a few …

As one major component of extracellular matrix (ECM) in the central nervous system,
chondroitin sulfate proteoglycans (CSPGs) have long been known as inhibitors enriched in …

In the developing or regenerating nervous system, migrating growth cones are exposed to
regulatory molecules that positively and/or negatively affect guidance. Chondroitin sulfate …

Proteoglycans influence aging and plasticity in the nervous system. Particularly prominent
are the chondroitin sulfate proteoglycans (CSPGs), which are generally inhibitory to neurite …

Proteoglycans (PGs) are complex macromolecules of the extracellular matrix (ECM) that
have a wide variety of effects on developing and regenerating neurons in vivo and in vitro …

The extension of axons through the major inhibitory component of the glial scar, chondroitin
sulfate proteoglycans (CSPGs), remains a key obstacle for regeneration following spinal …

Sulfated proteoglycans (PG s) may play a significant role in the regulation of neurite
outgrowth. They are present in axon-free regions of the developing nervous system and …

Soluble chondroitin sulfate proteoglycans (CSPGs), prepared from 10-d-old rat brain, were
added to the culture medium of PC12D cells containing NGF to examine the effects on NGF …

The current dogma in neural regeneration research implies that chondroitin sulfate
proteoglycans (CSPGs) inhibit plasticity and regeneration in the adult central nervous …